Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Kumari, Sonia ^a   Sherriff, Jennifer M ^a   Spooner, David ^a   Beckett, Robert ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL TUMOR; HUMAN; HYPERCHOLESTEROLEMIA; LAPAROTOMY; LYMPH NODE METASTASIS; MALE; MOTOR NEUROPATHY; NERVE CONDUCTION; PERIPHERAL NEUROPATHY; PERITONEUM METASTASIS; PRIORITY JOURNAL; SENSORY NEUROPATHY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE TUMOR;

EID: 84877827995     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009060     Document Type: Article

References (19)

1. Lin JS. An alternative treatment of hyperlipidaemia with red yeast rice: a case report. J Med Case Rep 2010;4:4.
2. Grieco A, Miele L, Pompili M, et al. Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol 2009;50:1273-7.
3. Heber D, Lembertas A, Lu QY, et al. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complent Med 2001;7:133-9.
4. Klimek M, Wang S, Ogunkanmi A. Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P T 2009;34:313-27.
5. Fung WT, Subramaniam G, Lee J, et al. Assessment of extracts from red yeast rice for herb-drug interaction by in-vitro and in-vivo assays. Sci Rep 2012;2:298.
6. Shang Q, Liu Z, Chen K, et al. A systematic review of Xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia. Evid Based Complement Altern Med 2012;2012:636547.
7. Feuerstein JS, Bjerke WS. Powdered red yeast rice and plant stanols and sterols to lower cholesterol. J Diet Suppl 2012;9:110-15.
8. Zhu L, Yau LF, Lu JG, et al. Cytoxic dehydromonacolins from red yeast rice. J Agric Food Chem 2012;60:934-9.
9. Becker DJ, Gordon RY, Halbert SC, et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009;150:830-9.
10. Hasani-Ranjbar S, Nayebi N, Moradi L, et al. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des 2010;16:2935-47.
11. Sikka P, Kapoor S, Bindra VK, et al. Statin intolerance: now a solved problem. J Postgrad Medicine 2011;57:321-8.
12. Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002;58:1333-7.
13. Backes JM, Howard PA. Association of HMG-CoA reductase inhibitors with neuropathy. Ann Pharmacother 2003;37:274-8.
14. Ziajka PE, Wehmeier T. Peripheral neuropathy and lipid lowering therapy. South Med J 1998;91:667-8.
15. Langen JJD, Puijenbroek EPV. HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands pharmacovigilance centre. Neth J Med 2006;64:334-8.
16. Otruba P, Kanovsky P, Hlustik P. Treatment with statins and involvement of the peripheral nervous system: results of a prospective clinical and neurophysiological follow-up. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:307-10.
17. Asif M, Siddiqui A, Scott LJ. Imatinib: a review of its use in the management of gastrointestinal stromal tumours. Drugs 2007;67:805-20.
18. Chakupurakal G, Etti RJO, Murray JA. Peripheral neuropathy as an adverse effect of imatinib therapy. J Clin Pathol 2011;64:456.
19. Ross DM. Peripheral neuropathy on imatinib treatment for chronic myeloid leukaemia: suspected adverse drug interaction with amlodipine. Intern Med J 2009;39:708.